Researchers from the University of Northern Colorado found that commercially available cannabis is "genetically divergent" from the research-grade cannabis coming out of the federal cannabis research farm at Ole Miss.
Alyson Martin, founder and editor of CannabisWire saw the Ole Miss cannabis when she visited the farm in 2013. She says "The cannabis in the barrels there was dry, looked like what most people know as "shake," and was full of seeds and stems."
"Research has demonstrated that Cannabis distributed by National Institute on Drug Abuse (NIDA) has lower levels of the principal medicinal cannabinoids (THC and CBD) and higher levels of degradation byproducts of cannabinoids (cannabinol, CBN)," the research noted. "Taken together, these results demonstrate the need for there to be greater diversity of Cannabis available for medical research."
You don't have to look very far to find solutions to this problem. Oregon is just one state producing twice as much cannabis as people are using, according to a recent study from the Oregon Liquor Control Commission. And Oregon has been overproducing marijuana for a while — leaving more than six years’ worth of supply sitting on shelves and at farms.
So there's really no justification for relying on poor quality cannabis for research purposes. Quality in, quality out.